Green Cures and Botanical Distribution, Inc. announces the launching of CBDOil.us and the addition of new products to the line Green Cures containing a minimum of 100mg of infused CBD oil
WINNETKA, Calif., Dec. 10, 2014 /PRNewswire/ — Green Cures & Botanical Distribution Inc. (OTC Pink: GRCU) (“Green Cures”) a cannabis and industrial hemp products innovator is pleased to announce the launching of CBDOil.us, the first product review and potency verification online platform for CBD-derived products in the U.S. market today. Management of Green Cures stated that CBDOil.us is the first online platform, where the online community will be able to learn about the potency and consistency of numerous CBD-derived/infused products that are currently being marketed and sold nationally in the U.S. Through each of the product review sections, which include CBD potency reports that have been conducted by certified U.S. Laboratories, the consumers, the public, and the investment community can learn about the CBD potency level in a product of their interest, and compare these potency levels to those being advertised by the different CBD product manufacturers and brands currently in the market.
“It also important to note that in accordance with federal guidelines, imported CBD-rich oil extracted from industrial hemp cannot exceed a level of Tetrahydrocannabinol (THC) higher than .3%,” commented Green Cures CEO Robert Calkin.
Management of Green Cures invited both the consumers and product manufacturers to upload their certified CBD potency reports to CBDOil.us, so that the online community can learn more about the products that they have either purchased or introduced to the market.
Additionally, the company announced the immediate availability of its one fluid ounce of CBD Tincture by Green Cures containing 100 mg of CBD-rich oil. CBD Tincture by Green Cures is exclusively available through allcbd.com, which is one of the company’s e-commerce platforms, where online consumers can purchase CBD-derived products from anywhere across the U.S., as permitted by law. CBD Tinctures by Green Cures (100 mg) are currently being offered in two different flavors, natural and strawberry. At the same time, the company informs to the public and the investment community that a potency report for the latest Tincture has been uploaded to allcbd.com. This report has been conducted on behalf of the company by a certified laboratory in the state of California. According to the new report, the CBD Tinctures by Green Cures offer 3.91 milligrams of infused CBD oil per milliliter; one fluid ounce contains 29.6 milliliters of infused oil.
As stated in previous releases, numerous properties and benefits of CBD are being investigated at academic research centers in the United States and elsewhere. The FDA has not evaluated the validity or truthfulness of these claims. As such, Green Cures management encourages its customers and the market in general to review the published research relating to the benefits and properties of CBD hemp oils and other CBD infused products, and to educate themselves on the use and benefits of these oils and products. Green Cures management will continue to monitor research results relating to the benefits and properties of CBD hemp oils and other products as well.
In closing, the company will provide additional updates as they become available.
About Green Cures & Botanical Distribution Inc.: Green Cures & Botanical Distribution Inc. is a development stage company that retails and wholesales nutritional, sports, hemp-infused and body care products. The company is currently Web-based and focuses on online retailing. Green Cures & Botanical Distribution Inc., operates a diverse portfolio of products and services within the botanical and cannabis industry, as permitted by law. From concept to production and distribution, Green Cures & Botanical Distribution Inc., is continuously creating and introducing products that promote a healthy life style.
FDA Statement: The statements contained in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.
Forward-looking statement: This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Forward-looking statements are identified by wording such as “scheduled (future sense)” “intend(s)”, “plan(s)” “expect(s)”, “believe(s)” “will” “estimate(s)”, “anticipate(s)”, “expect(s)”, “may”, “would”, “could” or “should” or, in each case, the negative thereof, other variations thereon, or comparable terminology that implies anticipated future deliverables. The Company disclaims any obligation or intention to update any forward-looking statement for any reason.
To view the original version on PR Newswire, visit:https://www.prnewswire.com/news-releases/green-cures-and-botanical-distribution-inc-announces-the-launching-of-cbdoilus-and-the-addition-of-new-products-to-the-line-green-cures-containing-a-minimum-of-100mg-of-infused-cbd-oil-300007532.html
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
